Lilly declares second-quarter 2025 dividend

Core Points - Eli Lilly and Company has declared a dividend of $1.50 per share for the second quarter of 2025, payable on June 10, 2025, to shareholders of record by May 16, 2025 [1] Company Overview - Eli Lilly is a pharmaceutical company focused on transforming scientific discoveries into healing solutions, with nearly 150 years of experience in pioneering life-changing medicines [2] - The company addresses significant health challenges, including diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers [2] - Eli Lilly is committed to ensuring the accessibility and affordability of its medicines while conducting innovative clinical trials that reflect global diversity [2]